Name (Synonyms) | Correlation | |
---|---|---|
drug1981 | Questionnaire by phone call Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D012859 | Sjogren's Syndrome NIH | 0.71 |
D001327 | Autoimmune Diseases NIH | 0.58 |
D015535 | Arthritis, Psoriatic NIH | 0.50 |
D008180 | Lupus Erythematosus, Systemic NIH | 0.41 |
D001168 | Arthritis NIH | 0.29 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002960 | Autoimmunity HPO | 0.58 |
HP:0002725 | Systemic lupus erythematosus HPO | 0.41 |
HP:0001369 | Arthritis HPO | 0.29 |
There is one clinical trial.
Rapid antigenic tests are not yet used in real life. Their contribution in the diagnostic strategy based on the gold standard including anamnesis, thoracic CT and PCR has not been evaluated. We propose to compare to the Gold-Standard defined above, the combination of an SARS-Cov-2 antigen, anamnesis and thoracic CT for the diagnosis of COVID-19 infection.
Description: Comparison of the Gold-Standard PCR, anamnesis, thoracic CT scan versus SARS-Cov-2 antigen, anamnesis and thoracic CT scan
Measure: Comparison of the proportion of patients classified as COVID-19 positive according to the 2 strategies Time: day 1Description: Number of diagnoses invalidated by the antigen + CT scan alone without the contribution of PCR.
Measure: Positive or negative Covid-19 test Time: day 1Description: Comparison of the proportion of patients with positive serology for SARS-Cov2 to the proportion of patients who were classified as COVID-19
Measure: Positive or negative character of the antibodies test Time: day 1Description: Comparison of the proportion of patients with positive serology for SARS-Cov2 to the proportion of patients who were classified as COVID-19 at the time of hospitalization
Measure: Positive or negative character of the antibodies test Time: day 21Description: Evolution of biological parameters as a function of time IgM IgA and IgG
Measure: Biological parameters Time: day 1Description: Evolution of biological parameters as a function of time IgM IgA and IgG
Measure: Biological parameters Time: Day 21Description: medical-economic comparison of the first-line use of the antigenic test
Measure: medical-economic comparison Time: day 1